Intense Pulsed Light Therapy for Hidrosadenitis Suppurativa
NCT ID: NCT03203122
Last Updated: 2017-06-29
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
20 participants
INTERVENTIONAL
2017-08-07
2019-08-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Patients are randomized to treatment in either left or right side, the other side works as control.
No sham treatment, but observers are blinded.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Study group
Patients are randomized to treatment of either right or left side. The other side works as control
IPL laser
IPL laser monthly. Vertical and horizontal treatment, one pass over. Settings according to fitzpatrick skin type
Comparator Group
Patients are randomized to treatment in either right or left side. The other side works as control
No sham treatment
The treatment is slightly painful, and noisy. Sham treatment impossible
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
IPL laser
IPL laser monthly. Vertical and horizontal treatment, one pass over. Settings according to fitzpatrick skin type
No sham treatment
The treatment is slightly painful, and noisy. Sham treatment impossible
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Fitzpatrick skin type I-II
Exclusion Criteria
* Unable to understand or communicate with study personnel
18 Years
65 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Zealand University Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University hospital Zealland
Roskilde, , Denmark
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Gregor Jemec, DMSc
Role: CONTACT
Email: gbj@regíonsjaelland.dk
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Peter T Riis, MD
Role: primary
Linnea Thorlacius, MD
Role: backup
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
REG-115-2016
Identifier Type: -
Identifier Source: org_study_id